Company Overview
Snapshot
Founded in December 2023 by Dovi Kelman, MilgoSense operates with 1–10 employees. The company is currently in its Pre-Funding stage, focusing on developing an AI-based diagnostic tool for schizophrenia.
Business overview
MilgoSense is an early-stage venture in the Health Tech & Life Sciences sector, specifically within digital healthcare and diagnostics. The company is developing a simple, non-invasive, remote, and AI-based diagnostic tool to disrupt the diagnosis, monitoring, and decision-making processes for schizophrenia. This technology aims to address the critical unmet need for an objective decision-support tool to facilitate early diagnosis and treatment, particularly for teenagers, thereby serving the healthcare provider market.
Log in to access full profile ›Company Intelligence Q&A
- When was MilgoSense founded?
- MilgoSense was founded in December 2023.
- Who founded MilgoSense?
- MilgoSense was founded by Dovi Kelman, who also serves as the CEO.
- What is MilgoSense's primary focus?
- MilgoSense is focused on developing an AI-based diagnostic tool for schizophrenia, aiming to provide a non-invasive and remote solution for early diagnosis and monitoring.
- What problem does MilgoSense aim to solve?
- MilgoSense aims to solve the lack of an objective decision-support tool for schizophrenia diagnosis, particularly to help prioritize and bring teenagers in distress to psychiatrists sooner, which can reduce long-term hospitalization and increase independent living.
- In which sector does MilgoSense primarily operate?
- MilgoSense operates primarily in the Health Tech & Life Sciences sector, with a focus on digital healthcare and diagnostics.